ClinicalTrials.gov
ClinicalTrials.gov Menu

Single-Dose Gene Replacement Therapy Clinical Trial for Patients With Spinal Muscular Atrophy Type 1 (STRIVE-EU)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03461289
Recruitment Status : Recruiting
First Posted : March 12, 2018
Last Update Posted : December 13, 2018
Sponsor:
Information provided by (Responsible Party):
AveXis, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : November 2020
  Estimated Study Completion Date : November 2020